Osmol Therapeutics
New Haven, US · Founded 2016
Biotech
Founders & leadership
BD
Brian DixonExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.3MraisedFeb 2022 · 4 investors · Biotechnology
Rule 506(c)$550KraisedJan 2017 · 4 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.